loading...
loading...A biopharmaceutical company, Neurocrine’s stock reflects advancements in neurological and endocrine therapies.
| Symbol | Spread | Sell | Buy | Change |
|---|---|---|---|---|
| AUDUSD | ||||
| EURUSD | ||||
| GBPUSD | ||||
| USDCAD |
| Symbol | Sell | Buy | Spread |
|---|---|---|---|
AUDUSD |
0.70017 |
0.70017 |
1.3 |
EURUSD |
0.70017 |
0.70017 |
1.3 |
GBPUSD |
0.70017 |
0.70017 |
1.3 |
USDCAD |
0.70017 |
0.70017 |
1.3 |
USDCHF |
0.70017 |
0.70017 |
1.3 |
USDJPY |
0.70017 |
0.70017 |
1.3 |
Neurocrine Biosciences Inc is a biopharmaceutical company focused on developing treatments for neurological and endocrine diseases. As a publicly traded stock, Neurocrine attracts investors interested in biotech. The company’s commitment to research and development enhances its growth potential in the pharmaceutical market.
Our mission is to empower traders with innovative technology and unparalleled support.
We value integrity, transparency, and Customer-centricity in every transaction.
Our app combines advanced MT4/MT5 features with a user-friendly interface for seamless trading.
Founded on a commitment to excellence, we strive to lead the global trading landscape.
Security and trust are at the core of our operations, ensuring a safe trading environment.
We are dedicated to providing 24/7 support to assist our users every step of the way.
Open a live account and start trading in minutes.
Deposit funds into your account using a variety of payment methods.
Access 1000+ instruments across multiple asset classes.
DOWNLOAD APP TRADER
Risk Warning:Trading in futures, options, forex and Over the Counter (OTC) products offered as Contract For Differences (CFDs)by Pacific Financial Derivatives Limited, company #973842 is speculative in nature and not appropriate for all investors.
Investors should only use risk capital when trading futures, options, forex and CFDs because there is always the risk of substantial loss. It is important investors carefully consider their objective, financial situation and level of experience. It is recommended that investors seek independent advice before trading. Account access, trade executions and system response may be adversely affected by market conditions, quote delays, system performance and other factors.
Copyright © 2025 Pacific Financial Derivatives Ltd. All Rights Reserved
Talk to us
